Finance

Lists
1099:HKG
Sinopharm
၁၅.၇၂ HK$
+၀.၄၅%
(+၀.၀၇၀) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1099...
Open
၁၅.၇၉ HK$
High
၁၅.၉၉ HK$
Low
၁၅.၆၇ HK$
Mkt. cap
ဋေ ၄.၉၁ ထ
Avg. vol.
၄.၈၅ သန်း
Volume
၅.၈၉ သန်း
Dividend
၅.၀၃%
Quarterly dividend
၀.၂၀ HK$
Ex-dividend date
၂၀၂၆ ဇွန် ၂၃
P/E ratio
၅.၉၀
52-wk high
၂၂.၃၄ HK$
52-wk low
၁၄.၅၅ HK$
EPS
၂.၆၇ HK$
Shares outstanding
၁၁၉.၂၈ ဋေ
No. of employees
၉ သောင်း
Open
၁၅.၇၉ HK$
High
၁၅.၉၉ HK$
Low
၁၅.၆၇ HK$
Mkt. cap
ဋေ ၄.၉၁ ထ
Avg. vol.
၄.၈၅ သန်း
Volume
၅.၈၉ သန်း
Dividend
၅.၀၃%
Quarterly dividend
၀.၂၀ HK$
Ex-dividend date
၂၀၂၆ ဇွန် ၂၃
P/E ratio
၅.၉၀
52-wk high
၂၂.၃၄ HK$
52-wk low
၁၄.၅၅ HK$
EPS
၂.၆၇ HK$
Shares outstanding
၁၁၉.၂၈ ဋေ
No. of employees
၉ သောင်း
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၁ နာရီ
Ardagh Metal Packaging (NYSE:AMBP): What Comes Next?
Macau Business
Macau Business
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
TradingView
TradingView
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၁၀ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm
CEO-
Employees၉.၀၄ သောင်း
Founded၂၀၀၃
Headquarters-
SectorHealth care provider
Last report
၂၀၂၆ ဩ ၂၄
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
ဋေ ၁.၄၂ သ / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၄၅ သ
ဋေ ၁.၄၄ သ
ဋေ ၁.၄၁ သ
ဋေ ၁.၄၂ သ
Cost of goods sold
ဋေ ၁.၃၅ သ
ဋေ ၁.၃၃ သ
ဋေ ၁.၃၁ သ
ဋေ ၁.၃၂ သ
Cost of revenue
ဋေ ၁.၃၅ သ
ဋေ ၁.၃၃ သ
ဋေ ၁.၃၁ သ
ဋေ ၁.၃၂ သ
Research and development expenses
၁၇.၂၆ ကုဋေ
-၁၇.၂၆ ကုဋေ
၄.၆၆ ကုဋေ
-၄.၆၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅၁၇.၃၇ ဋေ
၇၃၃.၅၃ ဋေ
၅၀၉.၅၆ ဋေ
၅၇၀.၀၉ ဋေ
Operating expense
၆၇၉.၈၈ ဋေ
၅၀၀.၂၆ ဋေ
၆၂၉.၁၅ ဋေ
၅၄၄.၉၁ ဋေ
Total operating expenses
ဋေ ၁.၄၁ သ
ဋေ ၁.၃၈ သ
ဋေ ၁.၃၈ သ
ဋေ ၁.၃၈ သ
Operating income
၄၁၂.၀၁ ဋေ
၅၄၀.၃၆ ဋေ
၃၀၇.၂၈ ဋေ
၄၂၅.၈၁ ဋေ
Other non operating income
၁၂.၀၈ ကုဋေ
-၄၂.၇၄ ကုဋေ
၃.၉၆ ကုဋေ
-၁၀.၀၈ ကုဋေ
EBT including unusual items
၃၆၇.၁၉ ဋေ
၃၉၁.၇၈ ဋေ
၂၈၉.၉၁ ဋေ
၄၀၄.၅၇ ဋေ
EBT excluding unusual items
၃၅၁.၄၃ ဋေ
၅၃၆.၃၄ ဋေ
၂၈၉.၉၈ ဋေ
၄၂၅.၁၄ ဋေ
Income tax expense
၉၀.၅၄ ကုဋေ
၁၁၈.၇၁ ဋေ
၇၁.၂၃ ကုဋေ
၁၀၅.၂၈ ဋေ
Effective tax rate
၂၄.၆၆%
၃၀.၃၀%
၂၄.၅၇%
၂၆.၀၂%
Other operating expenses
၉၁.၇၁ ကုဋေ
-၁၁၀.၄၅ ဋေ
၂၀.၄၅ ကုဋေ
-၃၉.၂၇ ကုဋေ
Net income
၁၈၄.၁၁ ဋေ
၁၈၄.၈၃ ဋေ
၁၄၁.၃၉ ဋေ
၁၉၈.၉၈ ဋေ
Net profit margin
၁.၂၇%
၁.၂၉%
၁.၀၀%
၁.၄၀%
Earnings per share
-
-
-
-
Interest and investment income
၃၆.၄၂ ကုဋေ
-
၁၇.၁၃ ကုဋေ
-
Interest expense
-၄၁.၂၆ ကုဋေ
-၈၄.၆၆ ကုဋေ
-၃၈.၃၈ ကုဋေ
-၅၀.၅၈ ကုဋေ
Net interest expenses
-၄.၈၃ ကုဋေ
-၈၄.၆၆ ကုဋေ
-၂၁.၂၆ ကုဋေ
-၅၀.၅၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၆၅.၈၀ ဋေ
၅၉၁.၂၂ ဋေ
၃၅၈.၁၃ ဋေ
၄၇၇.၉၀ ဋေ
Gain or loss from assets sale
၁.၁၈ ကုဋေ
-၂.၀၅ ကုဋေ
-
-၁.၄၃ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ